RYAH Group, Inc. it has entered into a non-binding letter of intent Emotional Intelligence Ventures. The collaboration is aimed at developing new delivery solutions for Ei.Ventures' psychoactive compounds using RYAH's Smart devices and data analytics, with the goal of advancing patient care to further address the current global mental health crisis. The executed Letter of Intent initiates a collaboration that is anticipated to culminate into the parties negotiating and finalizing certain definitive research and development (R&D), licensing, and distribution agreements between the parties (the Definitive Agreements). The Definitive Agreements, if entered into, are expected to provide for RYAH's licensing of certain intellectual property relating to its Smart Patch device and data analytics to Ei.Ventures for, among other things, R&D and potential commercialization, by Ei.Ventures, of certain psychedelic mushroom formulations in conjunction with RYAH's Smart Patch hardware, software, and patient session analytics. It is anticipated the terms of any such licensing and R&D agreements, including any potential hardware and software customizations, will be agreed upon in the Definitive Agreements.